BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38372888)

  • 1. Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line.
    Ono T; Noguchi R; Osaki J; Akiyama T; Adachi Y; Kojima N; Toda Y; Fukushima S; Yoshimatsu Y; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2024 May; 37(3):854-864. PubMed ID: 38372888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of NCC-DFSP3-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Nakagawa M; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2020 Jul; 33(3):894-903. PubMed ID: 32356243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1.
    Oyama R; Kito F; Qiao Z; Sakumoto M; Shiozawa K; Toki S; Yoshida A; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2019 Jan; 55(1):62-73. PubMed ID: 30411273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of NCC-DFSP4-C1: a novel cell line from a patient with dermatofibrosarcoma protuberans having the fibrosarcomatous transformation.
    Akiyama T; Yoshimatsu Y; Noguchi R; Sin Y; Osaki J; Ono T; Adachi Y; Tsuchiya R; Toda Y; Ogura K; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
    Hum Cell; 2023 Nov; 36(6):2187-2194. PubMed ID: 37490236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
    Rota S; Franza A; Fabbroni C; Paolini B; Greco FG; Alessi A; Padovano B; Casali P; Sanfilippo R
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1969. PubMed ID: 38279510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas.
    Szollosi Z; Scholtz B; Egervari K; Nemes Z
    J Clin Pathol; 2007 Feb; 60(2):190-4. PubMed ID: 16731589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans.
    Maki RG; Awan RA; Dixon RH; Jhanwar S; Antonescu CR
    Int J Cancer; 2002 Aug; 100(6):623-6. PubMed ID: 12209598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues.
    Wang J; Hisaoka M; Shimajiri S; Morimitsu Y; Hashimoto H
    Diagn Mol Pathol; 1999 Sep; 8(3):113-9. PubMed ID: 10565681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of COL1A1-PDGFB fusion gene detection by fluorescence in situ hybridization in biopsy tissue of dermatofibrosarcoma protuberans.
    Zhang Z; Chen H; Chen M; He X; Wang Y; Zhang H
    J Dermatol; 2017 Jul; 44(7):798-802. PubMed ID: 28150334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and clinicopathological analysis of dermatofibrosarcoma protuberans.
    Walluks K; Chen Y; Woelfel C; Yang L; Cui T; Seliger C; Geier C; Knösel T; Hauke S; Petersen I
    Pathol Res Pract; 2013 Jan; 209(1):30-5. PubMed ID: 23207290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.
    Rutkowski P; Klimczak A; Ługowska I; Jagielska B; Wągrodzki M; Dębiec-Rychter M; Pieńkowska-Grela B; Świtaj T
    Eur J Surg Oncol; 2017 Jun; 43(6):1134-1141. PubMed ID: 28365129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB.
    Shimizu A; O'Brien KP; Sjöblom T; Pietras K; Buchdunger E; Collins VP; Heldin CH; Dumanski JP; Ostman A
    Cancer Res; 1999 Aug; 59(15):3719-23. PubMed ID: 10446987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
    Koseła-Paterczyk H; Rutkowski P
    Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.
    Sjöblom T; Shimizu A; O'Brien KP; Pietras K; Dal Cin P; Buchdunger E; Dumanski JP; Ostman A; Heldin CH
    Cancer Res; 2001 Aug; 61(15):5778-83. PubMed ID: 11479215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Chromosomal Translocation Associated With COL1A2-PDGFB Gene Fusion in Dermatofibrosarcoma Protuberans: PDGF Expression as a New Diagnostic Tool.
    Nakamura I; Kariya Y; Okada E; Yasuda M; Matori S; Ishikawa O; Uezato H; Takahashi K
    JAMA Dermatol; 2015 Dec; 151(12):1330-1337. PubMed ID: 26332510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans.
    Eilers G; Czaplinski JT; Mayeda M; Bahri N; Tao D; Zhu M; Hornick JL; Lindeman NI; Sicinska E; Wagner AJ; Fletcher JA; Mariño-Enriquez A
    Mol Cancer Ther; 2015 Jun; 14(6):1346-53. PubMed ID: 25852058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
    Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
    J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of gene mutations in three cases of dermatofibrosarcoma protuberans (DFSP): ordinary DFSP, DFSP with fibrosarcomatous lesion (DFSP-FS) and lung metastasis of DFSP-FS.
    Saeki H; Hoashi T; Tada Y; Ashida R; Kuwano Y; Le Pavoux A; Tsunemi Y; Shikada J; Torii H; Kawabata Y; Kikuchi K; Tamada Y; Matsumoto Y; Tamaki K
    J Dermatol Sci; 2003 Dec; 33(3):161-7. PubMed ID: 14643521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib in the treatment of dermatofibrosarcoma protuberans.
    Labropoulos SV; Razis ED
    Biologics; 2007 Dec; 1(4):347-53. PubMed ID: 19707305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatofibrosarcoma protuberans: a study of clinical, pathologic, genetic, and therapeutic features in Korean patients.
    Zheng Z; Piao J; Lee JH; Kim SE; Kim SC; Chung KY; Roh MR
    Yonsei Med J; 2015 Mar; 56(2):440-6. PubMed ID: 25683993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.